TY - JOUR
T1 - Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging
T2 - How High Should We Go?
AU - Rosenkrantz, Andrew B.
AU - Parikh, Nainesh
AU - Kierans, Andrea S.
AU - Kong, Max Xiangtian
AU - Babb, James S.
AU - Taneja, Samir S.
AU - Ream, Justin M.
N1 - Funding Information:
Support : This study was supported by the Joseph and Diane Steinberg Charitable Trust .
Publisher Copyright:
© 2016 The Association of University Radiologists.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Rationale and Objectives: The aim of this study was to assess prostate cancer detection using a broad range of computed b-values up to 5000 s/mm2. Materials and Methods: This retrospective Health Insurance Portability and Accountability Act-compliant study was approved by an institutional review board with consent waiver. Forty-nine patients (63 ± 8 years) underwent 3T prostate magnetic resonance imaging before prostatectomy. Examinations included diffusion-weighted imaging (DWI) with b-values of 50 and 1000 s/mm2. Seven computed DWI image sets (b-values: 1000, 1500, 2000, 2500, 3000, 4000, and 5000 s/mm2) were generated by mono-exponential fit. Two blinded radiologists (R1 [attending], R2 [fellow]) independently evaluated diffusion weighted image sets for image quality and dominant lesion location. A separate unblinded radiologist placed regions of interest to measure tumor-to-peripheral zone (PZ) contrast. Pathologic findings from prostatectomy served as reference standard. Measures were compared between b-values using the Jonckheere-Terpstra trend test, Spearman correlation coefficient, and generalized estimating equations based on logistic regression for correlated data. Results: As b-value increased, tumor-to-PZ contrast and benign prostate suppression for both readers increased (r = +0.65 to +0.71, P ≤ 0.001), whereas anatomic clarity, visualization of the capsule, and visualization of peripheral-transition zone edge decreased (r = -0.69 to -0.75, P ≤ 0.003). Sensitivity for tumor was highest for R1 at b1500-3000 (84%-88%) and for R2 at b1500-2500 (70%-76%). Sensitivities for both pathologic outcomes were lower for both readers at both b1000 and the highest computed b-values. Sensitivity for Gleason >6 tumor was highest for R1 at b1500-3000 (90%-93%) and for R2 at 1500-2500 (78%-80%). The positive predictive value for tumor for R1 was similar from b1000 to 4000 (93%-98%) and for R2 was similar from b1500 to 4000 (88%-94%). Conclusions: Computed b-values in the range of 1500-2500 s/mm2 (but not higher) were optimal for prostate cancer detection; b-values of 1000 or 3000-5000 exhibited overall lower performance.
AB - Rationale and Objectives: The aim of this study was to assess prostate cancer detection using a broad range of computed b-values up to 5000 s/mm2. Materials and Methods: This retrospective Health Insurance Portability and Accountability Act-compliant study was approved by an institutional review board with consent waiver. Forty-nine patients (63 ± 8 years) underwent 3T prostate magnetic resonance imaging before prostatectomy. Examinations included diffusion-weighted imaging (DWI) with b-values of 50 and 1000 s/mm2. Seven computed DWI image sets (b-values: 1000, 1500, 2000, 2500, 3000, 4000, and 5000 s/mm2) were generated by mono-exponential fit. Two blinded radiologists (R1 [attending], R2 [fellow]) independently evaluated diffusion weighted image sets for image quality and dominant lesion location. A separate unblinded radiologist placed regions of interest to measure tumor-to-peripheral zone (PZ) contrast. Pathologic findings from prostatectomy served as reference standard. Measures were compared between b-values using the Jonckheere-Terpstra trend test, Spearman correlation coefficient, and generalized estimating equations based on logistic regression for correlated data. Results: As b-value increased, tumor-to-PZ contrast and benign prostate suppression for both readers increased (r = +0.65 to +0.71, P ≤ 0.001), whereas anatomic clarity, visualization of the capsule, and visualization of peripheral-transition zone edge decreased (r = -0.69 to -0.75, P ≤ 0.003). Sensitivity for tumor was highest for R1 at b1500-3000 (84%-88%) and for R2 at b1500-2500 (70%-76%). Sensitivities for both pathologic outcomes were lower for both readers at both b1000 and the highest computed b-values. Sensitivity for Gleason >6 tumor was highest for R1 at b1500-3000 (90%-93%) and for R2 at 1500-2500 (78%-80%). The positive predictive value for tumor for R1 was similar from b1000 to 4000 (93%-98%) and for R2 was similar from b1500 to 4000 (88%-94%). Conclusions: Computed b-values in the range of 1500-2500 s/mm2 (but not higher) were optimal for prostate cancer detection; b-values of 1000 or 3000-5000 exhibited overall lower performance.
KW - Diffusion magnetic resonance imaging
KW - Imaging
KW - Magnetic resonance imaging
KW - Neoplasms
KW - Prostate
UR - http://www.scopus.com/inward/record.url?scp=84960844386&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84960844386&partnerID=8YFLogxK
U2 - 10.1016/j.acra.2016.02.003
DO - 10.1016/j.acra.2016.02.003
M3 - Article
C2 - 26992738
AN - SCOPUS:84960844386
SN - 1076-6332
VL - 23
SP - 704
EP - 711
JO - Academic Radiology
JF - Academic Radiology
IS - 6
ER -